NPI registry status
Active
2026 NPPES data Specialist NPI 1598968000 MD
Verify on CMS → Molouk Rahnema, MD
Specialist in Las Vegas, Nevada.
This profile is drawn from the federal National Provider Identifier Registry (CMS NPPES), which lists more than 7 million U.S. healthcare providers - including 69,608 in Specialist, and covers specialty classification, practice address, and Medicare Part D prescribing data when reported. According to CMS, every field reflects the provider's official federal registration, see our methodology.
Federal data, no proprietary rating.
We show these CMS records as-is - no composite score, no star rating, no editorial opinion layered on top.
Prescribing volume
7K
Medicare Part D claims · 725 beneficiaries · Specialist avg: 1K
Generic prescribing
46%
generic claims · 48% brand-name · higher generic rates reduce patient out-of-pocket costs
MIPS score
25.9/100
▼ 57 pts below national avg 83.1 · Below average
Industry payments
$13.3K
174 payments · CMS Open Payments (Sunshine Act)
Source: CMS Medicare Part D Prescriber Public Use File, 2023
Compiled from official public sources by the PlainDoctor editorial team.
What the federal data shows
Molouk Rahnema, MD reported a CMS MIPS final score of 25.9/100 - below the 83.1 national average - and filed 6,861 Medicare Part D claims in 2023.
- 25.9/100
- MIPS score · -57 vs avg
- 7K
- Part D claims, 2023
- 46%
- generic prescribing
- $13.3K
- industry payments (Sunshine Act)
Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) - no proprietary rating or editorial opinion is applied.
Molouk Rahnema, MD's MIPS score vs every scored U.S. clinician
CMS Merit-based Incentive Payment System (MIPS) final score, 2023, the federal quality measure
26 3rd percentile higher than 3% of 477,587 scored providers
Each bar is a band; taller bars hold more scored providers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source CMS Merit-based Incentive Payment System (MIPS) · 2023
Where Molouk Rahnema, MD sits
This provider among specialist peers
Across the 4,869 specialist providers who report both Medicare Part D prescribing and a MIPS quality score, Molouk Rahnema, MD writes more Part D claims than 94% of them and scores higher on MIPS quality than 11% - placing this provider in the high-volume, lower-quality quadrant. Volume reflects patient-panel size and specialty, not quality; the two axes are independent.
Part D claim volume vs MIPS quality, by specialty percentile
Each dot is one specialist peer from a representative sample of 60; the gold marker is Molouk Rahnema, MD. Source: CMS Medicare Part D Prescriber data and the CMS Merit-based Incentive Payment System, 2023.
What does the federal data show about Molouk Rahnema, MD?
Below national averagePrimary specialty
Specialist
Medicare Part D claims
6,861 365% vs specialty avg
MIPS final score
25.9/100 57.2 pts vs avg
Specialty distribution in Nevada
How Specialist compares to other specialties among Nevada providers
Medicare quality performance, MIPS
Molouk Rahnema, MD's 2023 MIPS final score plotted against the Specialist national average
- MIPS Final Score
- 25.9/100
- vs 83.1 national avg · 2023 performance year
MIPS final score (Specialist) - 25.9/100 vs national avg 83.1
How MIPS and board certification work
The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.
Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).
Molouk Rahnema, MD appears in the CMS NPPES registry as a Specialist provider holding MD credentials at 653 N TOWN CENTER DR, Las Vegas, NV, 89144, with a listed phone of (702) 701-8400. NPI 1598968000 was issued on 06/11/2007.
Medicare Part D records for calendar year 2023 show 6,861 prescription claims written by this provider, covering 725 Medicare beneficiaries and totaling roughly $4.4 million in drug spend, split 48% brand-name and 46% generic by claim count. On the CMS Merit-based Incentive Payment System, this provider earned a Final Score of 25.9/100 for the 2023 performance year (Quality 25, Cost 53.1), compared with the national average of 83.1.
Specialist is a high-volume specialty nationwide, with 69,608 enrolled providers across 55 states and an average of 1,474 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline.
Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist, always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.
Practice Address
Provider Details
| NPI | 1598968000 |
|---|---|
| Specialty | Specialist |
| Credentials | MD |
| Gender | Female |
| NPI Issued | 06/11/2007 |
CMS Quality Score (MIPS)
Merit-based Incentive Payment System (MIPS) scores from CMS, 2023 performance year.
25.9251
Final Score
Avg: 83.1
25
Quality
53.0835
Cost
Reporting: Individual
Industry payments received (2024) - CMS Open Payments transparency data
The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for Molouk Rahnema, MD. Source: openpaymentsdata.cms.gov.
Total received
$13.3K
Largest payer
Lilly USA, LLC
Most common payment type
Food and Beverage
Industry payments are not necessarily indicators of bias, they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.
Brand vs generic prescribing mix · Above average
Molouk Rahnema, MD - brand share 48.0%
Specialist average
48% brand-name claims vs 46% generic, on 6,861 2023 Medicare Part D claims.
The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.
Medicare Part D Prescribing Data
CMS Medicare Part D prescriber-level data for calendar year 2023.
6,861
Total Claims
$4.4M
Total Drug Cost
725
Medicare Beneficiaries
Prescribing Breakdown
- 30-Day Fills
- 17,220
- Total Day Supply
- 513,811
- Brand vs Generic
- 48% brand / 46% generic
- Brand Drug Cost
- $4.2M
- Generic Drug Cost
- $141K
Patient Demographics
- Average Patient Age
- 72.7 years
- Avg HCC Risk Score
- 1.53
- Gender Split
- 60% female / 40% male
- Age Distribution
- <65: 68, 65-74: 347, 75-84: 265, 85+: 45
Top Prescribed Drugs (Medicare Part D)
Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.
What Molouk Rahnema, MD prescribes most
Top Medicare Part D drugs by claim count, 2023
- Levothyroxine Sodium
Levothyroxine Sodium
689 claims
- Metformin Hcl
Metformin Hcl
412 claims
- Ozempic
Ozempic
382 claims
- Atorvastatin Calcium
Atorvastatin Calcium
356 claims
- Trulicity 259
Trulicity
259 claims
- Alendronate Sodium 219
Alendronate Sodium
219 claims
- Jardiance 185
Jardiance
185 claims
- Losartan Potassium 145
Losartan Potassium
145 claims
| Drug | Claims |
|---|---|
| Levothyroxine Sodium | 689 |
| Metformin Hcl | 412 |
| Ozempic Semaglutide | 382 |
| Atorvastatin Calcium | 356 |
| Trulicity Dulaglutide | 259 |
| Alendronate Sodium | 219 |
| Jardiance Empagliflozin | 185 |
| Losartan Potassium | 145 |
| Synthroid Levothyroxine Sodium | 145 |
| Synjardy Xr Empagliflozin/Metformin Hcl | 134 |
* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.
Specialist Overview
How Molouk Rahnema, MD fits within the Specialist landscape nationally.
69,608
Specialist Providers in US
55
States with Specialist
1,474
Avg Claims per Provider
Molouk Rahnema, MD's 6,861 claims are above the specialty average of 1,474.
Nearby Specialist Providers in Nevada
Other clinicians with the same primary specialty enrolled in Nevada, drawn from the same CMS NPPES roster as Rahnema.
Dr. Karen Abbott
MD
Reno, NV
Dr. Gary Abrass
M.D.
Reno, NV
Dr. George Addison
M.S. ED.
Las Vegas, NV
Dr. Miriam Adelson
M.D.
Las Vegas, NV
Dr. Paparao Adusumilli
M.D.
Nellis Afb, NV
Compare Specialist nationally: see state-by-state distribution →
Before you book an appointment
Use this federal record as your verification checklist, not as a recommendation.
- Confirm the NPI record is current in the official CMS registry, providers update their own NPPES details, and moves can lag. Verify this NPI
- Check the active license and any disciplinary history with the Nevada medical board, federal registration is not a license check. Credential verification guide
- Weigh a second option: compare this provider with a nearby Specialist peer on Medicare volume and prescribing patterns. Compare providers
Medicare Part D and MIPS figures describe practice patterns in federal programs only, they are not quality ratings, and PlainDoctor does not rate, rank, or recommend providers.
Healthcare Guides
Learn more about finding, verifying, and understanding healthcare providers.
How to Find a Doctor
Step-by-step guide to choosing a provider
Verify Credentials
Check NPI, board certification & license status
Medical Specialties Explained
Who treats what and how specialties differ
Understanding Medicare Claims Data
What prescribing data reveals about a provider
In-Network vs Out-of-Network
How insurance networks affect your costs
Telehealth Guide
Virtual care options and coverage in 2026
Explore Nevada
Frequently Asked Questions
What is Molouk Rahnema, MD's specialty? ▼
Molouk Rahnema, MD specializes in Specialist and practices in Las Vegas, Nevada. Credentials: MD.
How much does Molouk Rahnema, MD prescribe under Medicare Part D? ▼
In 2023, Molouk Rahnema, MD wrote 6,861 Medicare Part D claims totaling $4.4M in drug costs for 725 beneficiaries.
What is Molouk Rahnema, MD's Medicare quality score? ▼
Molouk Rahnema, MD has a CMS MIPS Final Score of 25.9/100 (Quality: 25, Cost: 53.1). The national average MIPS Final Score is 83.1. Source: CMS Merit-based Incentive Payment System (MIPS) 2023.
Where is Molouk Rahnema, MD located? ▼
Molouk Rahnema, MD is located at 653 N TOWN CENTER DR, Las Vegas, NV, 89144. Phone: (702) 701-8400.
What is Molouk Rahnema, MD's NPI number? ▼
Molouk Rahnema, MD's National Provider Identifier (NPI) is 1598968000, issued on 06/11/2007.
Does Molouk Rahnema, MD prescribe more brand-name or generic drugs? ▼
Molouk Rahnema, MD's prescribing is 48% brand-name and 46% generic drugs by claim count, with $4.2M in brand drug costs.
How many Specialist providers are there in the US? ▼
There are 69,608 Specialist providers across 55 states in the US. The average Specialist provider writes 1,474 Medicare Part D claims per year.
What drugs does Molouk Rahnema, MD prescribe most often? ▼
Based on 2023 Medicare Part D data, Molouk Rahnema, MD's most frequently prescribed drugs include Levothyroxine Sodium, Metformin Hcl, Ozempic. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does Molouk Rahnema, MD accept Medicare? ▼
Molouk Rahnema, MD appears in CMS Medicare data with 6,861 Part D claims and 725 Medicare beneficiaries in 2023. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify Molouk Rahnema, MD's credentials? ▼
Molouk Rahnema, MD's NPI is 1598968000 with credentials MD. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.
Data Sources
View source datasets and methodology notes
- Provider Directory
- CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
- Specialty Classification
- NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
- Prescribing Data
- CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
- Quality Performance
- CMS Merit-based Incentive Payment System (MIPS) - 2023 performance year.
- Limitations
- Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.
See our complete data methodology for details on how we collect and process government data.
Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).
Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology
Compiled from official public sources by the PlainDoctor editorial team.
Every figure on PlainDoctor is rendered directly from the federal CMS NPPES registry, Medicare Part D, MIPS, and Open Payments records, no number is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.